Monday, 21 Dec 2020 02:55 PM MYT
Mah Sing said the first six production lines at it’s first glove manufacturing factory in Kapar, Klang would be operational as planned in the second quarter of 2021. Picture via Facebook/Mah Sing Group
Subscribe to our Telegram channel for the latest updates on news you need to know.
KUALA LUMPUR, Dec 21 Mah Sing Group Bhd has received 99.996 per cent shareholders’ approval for its proposed diversification into glove manufacturing and trading, and related healthcare products via Mah Sing Healthcare Sdn Bhd.
It said the first six production lines at Mah Sing’s first glove manufacturing factory in Kapar, Klang would be operational as planned in the second quarter of 2021, followed by another six lines expected to be ready in the third quarter, with a total maximum capacity of up to 3.68 billion pieces of gloves per annum.